PASSconviction 3published 2026-09-09

MLKN — MillerKnoll, Inc. · 2026-09-09 · Verdict: PASS · Conviction 3

Price $22.21 (screen row, 2026-09-09 run; no live quote) · Mkt cap $1.53B · EV $2.64B · EV/normalised EBIT 11.8x · EV/normalised after-tax profit 15.7x · FCF yield 5.1% · Net debt $1,118M · ADV $11.8M Sources read: 10-K filed 2026-07-20 for FY ended 2026-05-30 (Items 1, 1A, 7), 10-Q filed 2026-03-30, DEF 14A filed 2026-08-28, 8-Ks 2026-03-25 (Q3), 2026-06-03 (CEO transition), 2026-06-24 (Q4/FY), Form 4s trailing 12 months. No call transcript or prepared remarks were filed as an exhibit; the fetched transcript file is the same EX-99.1 press release.

Desk stats - Revenue trend: FY2026 net sales $3,841.7M, +4.7% (organic +3.6%); Q4 $1,004.2M, +4.4% (organic +3.7%). Of the $172M increase, price contributed ~$74M and currency ~$41M; volume across all three segments only ~$57M (10-K 2026, Item 7, Net Sales). - Normalised after-tax operating profit: GAAP operating earnings $198.3M; add CEO transition costs $2.6M (one-time, Owen separation, 8-K 2026-06-03); add amortisation of Knoll purchased intangibles $24.0M (non-cash purchase accounting from the 2021 deal); do not add back restructuring $13.5M (it was $14.8M in FY2025 and $8.1M in Q4 FY2026 alone, an annual cost); FY2026 impairment was zero. Normalised operating profit $224.9M vs GAAP $198.3M; at 25% tax, $168.7M (10-K 2026, Item 7, non-GAAP reconciliation). - EV / normalised after-tax profit: 15.7x. EV = $1,526.6M equity (68,733,063 shares, DEF 14A 2026-08-28) + $1,285.7M debt ($25.1M current, $1,260.6M long-term) − $167.7M cash = $2,644.6M; $2,708M including $63.3M redeemable non-controlling interests (8-K 2026-06-24, balance sheet). On the company's own adjusted operating earnings of $238.4M it is 14.8x. - Leverage: net debt / normalised EBITDA ($224.9M + $148.3M D&A = $373.2M) = 3.0x; the credit-facility-defined ratio is 2.80x (8-K 2026-06-24). Add $515.8M of lease liabilities and adjusted net debt is ~$1.63B. - Is the growth sustainable? Mostly no: price and currency, not volume, and the forward indicators point down. FY2026 orders $3,761.0M were +0.4%, Q4 orders fell 6.3% (organic −6.9%), backlog closed at $678.8M, down 10.8% (10-K 2026, Items 1 and 7). - What the screen got wrong: it added a $92.3M goodwill impairment from fiscal 2025 to fiscal 2026 operating income. That figure is exactly the $30.1M Global Retail plus $62.2M Holly Hunt charges taken in Q3 FY2025 (10-K 2026, Item 7, Goodwill); FY2026 carried no impairment at all. The screen's normalised EBIT of $290.6M overstates by $65.7M, its 12.0x becomes 15.7x, its 2.5x leverage becomes 3.0x. It also omitted the $25.1M current portion of debt.

1. What the business actually does

MillerKnoll designs and sells interior furnishings under Herman Miller, Knoll, DWR, HAY, Muuto, Holly Hunt, Maharam and Geiger (10-K 2026, Item 1). Three segments: North America Contract ($2,061.2M sales, 10.3% adjusted operating margin), International Contract ($674.0M, 8.6%), Global Retail ($1,106.5M, 3.0%), less a $65.7M corporate drag (10-K 2026, Item 7). About 53.6% of sales go through independent dealers; the largest customer is ~5% of sales and the top ten ~16%, so concentration is not an issue.

2. Why it is mispriced — the edge case

There is none I can find, and that decides the verdict. This is a $1.5B-cap Nasdaq name with $11.8M average daily volume, held 15.15% by BlackRock, 7.51% by Vanguard and 5.20% by Dimensional (DEF 14A 2026-08-28). No spin-off, no index deletion, no forced seller, no misread segment. The one thing that looked like an edge, the GAAP artefact the screen flagged, is a screen error rather than a market error. The stock has also already re-rated: the proxy states a $16.18 close on the last trading day of FY2026, against the $22.21 screen price.

3. GAAP to normalised, line by line (artifact_flag reconciliation)

FY2026 (10-K 2026, Item 7): operating earnings $198.3M (5.2% margin) → restructuring $13.5M → integration nil → Knoll intangible amortisation $24.0M → impairment nil → pension nil → CEO transition $2.6M → company adjusted operating earnings $238.4M (6.2%). FY2025: $50.5M → restructuring $14.8M, integration $28.3M, amortisation $24.1M, impairment $130.0M, pension $1.0M → $248.7M (6.8%). Normalised profit therefore fell 4.1% while GAAP profit quadrupled. Non-recurring? Impairments ran $22.3M in FY2024, $130.0M in FY2025, nil in FY2026, and restructuring recurred in all three; only the CEO transition cost is genuinely one-off.

Forward impairment risk is the sharpest fact in the filing. The FY2026 test left North America Contract with 45.5% cushion but International Contract at 3.1%, Global Retail at 1.1% and Coverings at 8.5%; the Knoll and Muuto trade names at 6.8% and 2.1% (10-K 2026, Items 7 and 1A). A 500bp cut to forecast sales alone would trigger $99.4M, $177.3M and $18.9M of goodwill impairment respectively; a 100bp higher discount rate another $29.2M and $36.6M. Goodwill plus indefinite-lived intangibles are $1,596.6M against $1,341.7M of equity.

4. Balance sheet and capital allocation

Liquidity is $571.7M including $404.0M of revolver availability (revolver matures April 2030, $309.2M drawn); maturities are light at $25.1M FY2027, $25.8M FY2028, $76.2M FY2029. FY2026 free cash flow was $199.9M CFO less $122.3M capex = $77.6M, 46% of normalised NOPAT, against $51.1M of declared dividends and $16.3M of buyback (down from $84.9M). FY2027 capex is guided to $125–135M, so free cash flow should shrink. Insiders own 5.51% as a group, but 2,619,379 of those 3,784,955 shares are exercisable options and 1,450,545 belong to the departed CEO. Open-market insider purchases in twelve months: zero (Form 4s, 90 rows, all grants, exercises and tax withholding).

5. Management: said versus did

Q3 guidance for Q4 was $955–995M of sales and $0.49–0.55 adjusted EPS; the company delivered $1,004.2M and $0.55, though adjusted operating expenses came in at $327.7M against a $311.5–321.5M guide (8-Ks 2026-03-25, 2026-06-24). The five-year record is worse: $100 invested at FY2021 was worth $39.84 at FY2026 year end against $103.11 for the peer group, and comp-committee adjusted operating earnings went $192.5M, $245.3M, $258.3M, $234.9M, $249.3M across FY2022–FY2026 (DEF 14A 2026-08-28, Pay Versus Performance). FY2027 guidance of $3.93–4.13B and $1.85–2.15 adjusted EPS has a midpoint level with FY2026's $1.86. There is no permanent CEO: Andi Owen retired 2026-06-30, COO Jeff Stutz is interim while the board searches (8-K 2026-06-03).

6. Valuation

Normalised NOPAT of $168.7M on $2,523M of invested capital is a 6.7% return on capital, against the 13.5%–16.5% discount rates the company's own model applies to these reporting units.

Probability-weighted $22.3 against $22.21: no margin of safety. Reverse DCF: unlevered free cash flow of roughly $124M (CFO $199.9M plus ~$46.5M after-tax cash interest less $122.3M capex) on a $2.64B enterprise value is a 4.7% yield, so at a 9% cost of capital the price implies MillerKnoll compounds unlevered free cash flow at about 4.3% in perpetuity, while orders grew 0.4% and backlog fell 10.8%.

7. Catalysts and timeline

Permanent CEO appointment, timing open. Q1 FY2027 results in late September 2026, the first read on whether Q4's −6.9% organic orders were only the prior-year pull-forward management blamed. The March 31, 2027 annual impairment test, where a 1.1% Global Retail cushion is one bad quarter from a charge.

8. Kill criteria (what would prove this PASS wrong)

  1. Two consecutive quarters of positive organic order growth in North America Contract, with backlog back above $760M.
  2. Full-year adjusted operating margin above 7.5% (FY2026: 6.2%).
  3. An open-market purchase above $500,000 by the incoming permanent CEO or the CFO (twelve-month record: zero).
  4. The FY2027 goodwill test showing Global Retail and International cushions above 10% with no impairment.

9. Verdict and summary

PASS, conviction 3. MillerKnoll screened at 12.0x normalised after-tax profit because the screen added a $92.3M goodwill impairment from fiscal 2025 to fiscal 2026 earnings that were never charged; strip the error out and it is 15.7x, leverage is 3.0x not 2.5x, and normalised operating profit fell 4.1% year over year. What is left is a fine collection of design brands attached to a company that grew revenue on price and currency rather than volume, took orders up 0.4%, ended the year with backlog down 10.8%, earns 6.7% on invested capital while its own model discounts these businesses at 13.5% to 16.5%, destroyed 60% of shareholder value over five years while peers gained, carries 1.1% and 2.1% goodwill and trade-name cushions on the units most at risk, is run by an interim CEO with no successor named, and has seen no insider buy a share in twelve months. At $22.21, up 37% from the $16.18 fiscal year-end close, the price already implies 4.3% perpetual free cash flow growth. No edge case, only a screen artefact, so leave it alone and revisit if orders turn.

Research for discussion, not investment advice. Positions and sizing are the reader's decision.

Source markdown: 2026-09-09_MLKN.md · how these notes are built · every verdict tracked since publication.

Research and education only. Nothing here is investment advice or a recommendation to buy or sell any security. No price targets are recommendations; positions and sizing are the reader's decision. Past performance does not predict future results.